Innate immune defences in the human uterus during pregnancy. 2007

A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
Department of Physiology, University of Toronto, Toronto, Ontario, Canada. aking6@staffmail.ed.ac.uk

The prevention of uterine infection is critical to appropriate fetal development and term delivery. The innate immune system is one component of the uterine environment and has a role in prevention of uterine infection. Natural antimicrobials are innate immune molecules with anti-bacterial, anti-viral and anti-fungal activity. We discuss two groups of natural antimicrobials in relation to pregnancy: (i) the defensins; and (ii) the whey acidic protein motif containing proteins, secretory leukocyte protease inhibitor (SLPI) and elafin. Human beta-defensins (HBD) 1-3 are expressed by placental and chorion trophoblast, amnion epithelium and decidua in term and preterm pregnancy. Elafin shows a similar pattern of localisation while SLPI is produced only by amnion epithelium and decidua. Evidence suggests that there is aberrant production of some natural antimicrobials in pathologic conditions of pregnancy. In preterm premature rupture of membranes (PPROM) levels of SLPI and elafin are reduced in amniotic fluid and fetal membranes, respectively. Elafin and HBD3 increase in chorioamnionitis and levels of the alpha-defensins, HNP1-3, increase in maternal plasma and amniotic fluid in women affected by microbial invasion of the uterus. In vitro culture studies have suggested a mechanism for increased production of natural antimicrobials in chorioamnionitis. Elafin, SLPI, HBD2 and 3 are all upregulated by inflammatory molecules in cells derived from gestational tissues. In summary, production of natural antimicrobials at key sites within the pregnant uterus suggests an important role in prevention of uterine infection during pregnancy and labour. Aberrant production of these molecules in PPROM and chorioamnionitis suggests that they also have a role in pathologic conditions. In particular, upregulation of these molecules by inflammatory molecules present in chorioamnionitis will ensure a robust response to infection.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014599 Uterus The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES. Fundus Uteri,Uteri,Uterine Cornua,Uterine Fundus,Uterus Cornua,Womb,Cornua, Uterine,Fundus Uterus,Fundus, Uterine,Uteri, Fundus,Wombs
D053481 Secretory Leukocyte Peptidase Inhibitor A proteinase inhibitor found in various BODILY SECRETIONS that coat mucosal surfaces such as SEMINAL PLASMA; CERVICAL MUCUS; and bronchial secretions. It plays a role in protecting epithelial tissues from LEUKOCYTE-derived serine proteases such as NEUTROPHIL ELASTASE. Antileukoprotease,Bronchial Mucus Elastase Inhibitor,Elastase Inhibitor, Mucus,Leukocyte Peptidase Inhibitor, Secretory,Mucus Protease Inhibitor,Mucus Proteinase Inhibitor,Secretory Leukocyte-Protease Inhibitor,Secretory Leukoprotease Inhibitor,Seminal Proteinase Inhibitor,Mucus Elastase Inhibitor,Protease Inhibitor, Mucus,Proteinase Inhibitor, Mucus,Secretory Leukocyte Protease Inhibitor
D053492 Elafin A secretory proteinase inhibitory protein that was initially purified from human SKIN. It is found in a variety mucosal secretions and is present at high levels in SPUTUM. Elafin may play a role in the innate immunity (IMMUNITY, INNATE) response of the LUNG. Peptidase Inhibitor 3, Skin-derived,Protease Inhibitor 3, Skin-derived,Protease Inhibitor WAP3,Skin-Derived Antileukoproteinase,Antileukoproteinase, Skin-Derived,Inhibitor WAP3, Protease,Peptidase Inhibitor 3, Skin derived,Protease Inhibitor 3, Skin derived,Skin Derived Antileukoproteinase
D023083 beta-Defensins DEFENSINS found mainly in epithelial cells. beta-Defensin,beta Defensin,beta Defensins

Related Publications

A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
July 1995, Journal of reproductive immunology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
September 1994, The Journal of endocrinology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
January 2018, Frontiers in immunology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
January 2014, Neonatology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
January 2004, American journal of obstetrics and gynecology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
August 2014, Immunology and cell biology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
January 2018, Virulence,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
September 2023, Frontiers in zoology,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
March 2007, Journal of animal science,
A E King, and R W Kelly, and J-M Sallenave, and A D Bocking, and J R G Challis
November 2021, Journal of cellular and molecular medicine,
Copied contents to your clipboard!